Insider Transactions in Q2 2024 at Celldex Therapeutics, Inc. (CLDX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
17,172
-37.91%
|
$601,020
$35.42 P/Share
|
|
Jun 14
2024
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,169
+18.7%
|
$181,521
$9.7 P/Share
|
|
Jun 14
2024
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
30,000
-76.78%
|
$1,020,000
$34.87 P/Share
|
|
Jun 14
2024
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+43.43%
|
$300,000
$10.38 P/Share
|
|
Jun 11
2024
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+46.71%
|
$30,000
$2.71 P/Share
|
|
Jun 07
2024
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
45,000
-95.51%
|
$1,575,000
$35.26 P/Share
|
|
Jun 07
2024
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
15,000
-62.31%
|
$525,000
$35.06 P/Share
|
|
Jun 07
2024
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.45%
|
$135,000
$9.7 P/Share
|
|
Jun 05
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
9,540
+21.2%
|
$95,400
$10.38 P/Share
|
|
Jun 03
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
8,006
-23.6%
|
$264,198
$33.6 P/Share
|
|
Jun 03
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,006
+19.09%
|
$80,060
$10.38 P/Share
|
|
Jun 03
2024
|
Richard M. Wright SR. VP & CCO |
SELL
Open market or private sale
|
Direct |
46,844
-44.4%
|
$1,545,852
$33.76 P/Share
|
|
Jun 03
2024
|
Richard M. Wright SR. VP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
67,469
+35.9%
|
$1,146,973
$17.75 P/Share
|
|
Jun 03
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
58,369
-81.35%
|
$1,926,177
$33.65 P/Share
|
|
Jun 03
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
64,658
+38.41%
|
$581,922
$9.7 P/Share
|
|
May 30
2024
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
20,853
-91.81%
|
$688,149
$33.73 P/Share
|
|
May 30
2024
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
20,853
+38.4%
|
$104,265
$5.9 P/Share
|
|
May 30
2024
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
35,000
-58.21%
|
$1,190,000
$34.05 P/Share
|
|
May 30
2024
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+29.37%
|
$250,000
$10.38 P/Share
|
|
May 30
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
38,719
-84.52%
|
$1,316,446
$34.07 P/Share
|
|
May 30
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
33,719
+17.1%
|
$236,033
$7.39 P/Share
|
|
May 30
2024
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
38,597
-80.97%
|
$1,273,701
$33.64 P/Share
|
|
May 30
2024
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,945
+30.96%
|
$214,725
$5.9 P/Share
|